To find more information on UCLH Early Phase Cancer Clinical Trials, including eligibility criteria, click the hyperlinked Local Project Reference (LRP) ID, which will take you to the UCLH Find a Study database.
Additional early phase clinical trials recruiting Sarcoma cohorts may be found in the Advanced Solid Tumour Trials Portfolio page.
IMMUNOSARC2Phase I - II trial of sunitinib plus nivolumab after standard treatment in advanced soft tissue and bone sarcomas | |
---|---|
Local Project Reference: | 17/0246 |
Principal Investigator: | Dr Sandra Strauss |
Drug Class/ Treatment: | Nivolumab (PD-1 inhibiting IgG4 Monoclonal Antibody) and Sunitinib (RTK Inhibitor) Combination Treatment - Nivolumab IV and Sunitinib Oral Administration |
Patient Population: | Advanced Soft Tissue and Bone Sarcomas |
Trial Hosted By - NIHR UCLH Clinical Research Facility (CRF) |
FaR-RMSAn overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma | |
---|---|
Local Project Reference: | 120376 |
Principal Investigator: | Dr. Maria Michelagnoli |
Drug Class/ Treatment: | Trial of various Immunotherapy, Targeted Therapy Agents and Radiotherapy. |
Patient Population: | Newly Diagnosed and Relapsed Rhabdomyosarcoma (RMS) Age >12 months and ≤25 years |
Trial Hosted By - UCLH Cancer Clinical Trials Unit (CCTU) |
SPEARHEAD-1A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR™ T cells in subjects with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma | |
---|---|
Local Project Reference: | 125255 |
Principal Investigator: | Dr. Sandra Strauss |
Drug Class/ Treatment: | ADP-A2M4 SPEAR™ T Cells - Genetically Modified T-Cells targeting MAGEA4 (Melanoma-Associated Antigen 4) |
Patient Population: | Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Age 16 - 75 |
Trial Hosted By - UCLH Cancer Clinical Trials Unit (CCTU) |